| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |